Beckman Coulter Inc has expanded its drugs of abuse test menu to include a DRI* Oxycodone Enzyme Immunoassay (OXYX). The assay is for the qualitative and semi-quantitative determination of oxycodone and its metabolite, oxymorphone, in human urine.
Read MoreBeckman Coulter Inc has expanded its Renal menu with the addition of Gentian* Cystatin C Immunoassay (CYSX), an assay for the quantitative determination of cystatin C in human serum and plasma.
Read More
Automating saves time and money, and enhances quality control
Read MoreBioMosaics Inc, a cancer biomarker development company, announced today that its monoclonal antibody product (clone 1G12) for detection of Glypican-3 (GPC3) has been validated for use as an immunohistochemical test for diagnosis of Hepatocellular Carcinoma (HCC).
Read More
G-Biosciences, Hardy Diagnostics, OraSure Technologies, Polymedco Inc, Stanbio, ViroStat Inc
Read More